Serge saxonov wiki. Letter from Serge Saxonov.
Serge saxonov wiki Education. Working at 10x. 97 a share. 4% bonuses, including company stock and options. Serge works at 10x Genomics as Co-founder and CEO. Kalita, Gabriella Stern, Rebecca Lowell Edwards, Steve Lipin, Sara Blask, Karen Wickre, Ailish Campbell, Anya Schiffrin, Tom Weber, Shernaz Daver, Jose Zamora, and Judi Mackey for their help. Serge Saxonov, the company's Chief Executive Officer, sold shares of the firm's Class A Common Stock. Affiliation 1 BioMedical Informatics Program, Stanford University, Stanford, CA 94305, USA. Early life 10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. Additionally, Serge Saxonov has had 2 past jobs including VP Applications at QuantaLife . is an American company incorporated in 2012 that develops and manufactures integrated systems for whole genome sequencing, exome sequencing and single cell transcriptomics. Share via: To our valued customers and partners: You may have seen news reports on some recent developments from the litigation campaign launched by Bio-Rad against 10x. 1 million for the second quarter, a 4% increase over the corresponding period of 2023, primarily driven by stronger contributions from consumables. Digital Creative Associates. Book Source: Digital Library of India Item 2015. 2020. 95M. Their career began as a First Employee, Founding Architect, Director of R andD at 23andme, transitioning through several roles including Vice President Applications at Quantalife before their current position since 2012. 9 In a noteworthy development for 10X Genomics, CEO Serge Saxonov adopted a Rule 10b5-1 trading arrangement on September 12, 2024, allowing for the sale of up to 35,600 shares of common stock, with In a noteworthy development for 10X Genomics, CEO Serge Saxonov adopted a Rule 10b5-1 trading arrangement on September 12, 2024, allowing for the sale of up to 35,600 shares of common stock, with As Chief Executive Officer at 10X GENOMICS INC, Serge Saxonov made $8,286,050 in total compensation. View Serge Saxonov's profile for company associations, background information, and partnerships. Download Citation | On Jan 1, 2023, Alex Philippidis and others published Space Race: 10x CEO Serge Saxonov Discusses Single Cell and Spatial Biology on “Close to the Edge” | Find, read and What is the salary of Dr D? As the Co-Founder and CEO & Director of 10x Genomics, the total compensation of Dr D at 10x Genomics is $654,993. 10x Genomics, Inc. For its 2023 fiscal year, 10X GENOMICS INC, listed the following board members on its annual proxy statement to the SEC. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. The shares were sold on November 22 at an average Declaration DECLARATION OF EDWARD EGAN SMITH IN SUPPORT OF DEFENDANTS MOTION FOR SUMMARY JUDGMENT OR, ALTERNATIVELY, SUMMARY ADJUDICATION Filed by: Iwei Yeh (Defendant); Serge Saxonov (Defendant) - Document December 29, 2021. " (Source 10x Genomics Expands in Pleasanton, California Karla Brown, Mayor of City of Pleasanton; Serge Saxonov, Co-founder and CEO of 10x Genomics (seated); and Ben Hindson, Co-founder and Chief Serge Saxonov's 8 research works with 1,513 citations and 1,035 reads, including: A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters Co-Founders Serge Saxonov and Ben Hindson give us a corporate overview and demonstrate the Chromium single cell platform, and later we are given a demonstration of the company's Xenium in situ gene expression technology. Rest assured, we have been well prepared for any outcome to our litigation and let us Serge Saxonov has filed for patents to protect the following inventions. See the full leadership team at Craft. We thank Serge Saxonov for his help with the e proteome database. CEO / President--The average 10X Genomics executive compensation is $275,564 a year. Serge Saxonov, CEO & Co-Founder 10x Genomics (See Disclosures) “Foresite Capital’s deep industry knowledge and in-house expertise has helped fuel our mission to outsmart cancer resistance. 10x Genomics co-founder and CEO Serge Saxonov, PhD “What they do is they enable customers to more easily, more routinely go through their experiments and generate results, which makes for better Serge Saxonov, Iraj Daizadeh, Alexei Fedorov and Walter Gilbert* Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA Received August 23, 1999; Revised and Accepted October 25, 1999 ABSTRACT To aid studies of molecular evolution and to assist in gene prediction research, we have constructed an Serge Saxonov is on Facebook. Serge Saxonov Net Worth (2024) | wallmine 10x Genomics, Inc. Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Serge Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. be/S_SD8WMK8WIThis installment of the NextTech Speaker series features Serge Saxonov, co-founder of 10x Genomics, sharing the Serge Saxonov is the Co-founder & CEO at 10X Genomics. This kind of collaboration is essential to building a strong and effective workplace, and it’s our goal to create an inclusive environment that reflects the Serge Saxonov co-founded 10x Genomics in 2012. As the company’s CEO, Saxonov defined 10x’s vision and strategy, contributed to core inventions, and has led the company 10x Genomics was founded in 2012 by Serge Saxonov, Ben Hindson and Kevin Ness to create advanced testing equipment for use in cellular biology. (NASDAQ:TXG) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ETCompany Participants. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today several changes to its executive team. Serge is based out of San Francisco Bay Area and works in the Biotechnology Research industry. 10xGenomics and Serge Saxonov (CEO and Co-founder) – The line of experiments, A research – two types of human genes, A compression, pulling, launch, oxidation, healing, tests on a blue substance, creation of a medicine. After his graduation, he had to leave the capital due to lack of jobs at the time, and briefly worked as a truck driver between the cities of The company was founded in 2012 by Chief Executive Serge Saxonov, the founding director of research at 23andMe, and Chief Scientist Ben Hindson, who founded startup QuantaLife, which was sold to View the profiles of people named Serge Saxonov. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co-Founder 10x Genomics, Inc. Saxonov and Hindson became Bio-Rad employees, but they left Bio-Rad in April 2012 and formed 10X in July 2012. 75, well above its $39 initial price offering starting point. Regarding Chromium, he said the company was working on advances in sensitivity, cell recovery, throughput and scale, and ease of use, with the ultimate goal of driving the cost per sample down to $100. About the talk: 23andMe's Personal Genome Service is TIME Magazine's 2008 Invention of the Year. His answer? Genomics. He has violet eyes, an upturned nose and defined chin, similar traits to his father Wazuki. We will host a question-and-answer session 10x Genomics, Inc. Details can be seen in Serge Saxonov's Latest Holdings Summary section. Serge is a type of twill fabric that has diagonal lines or ridges on both inner and outer surfaces via a two-up, two-down weave. China's gone almost, I would say, sort of effectively 100 percent in the context of the fact that people are opening. 10x Genomics is a leader in single-cell and emerging areas of genomic analysis, Our CEO Serge Saxonov was interviewed on Bloomberg TV about our latest $35M funding & how it will enable us to further accelerate the understanding of 10X Genomics' CEO, Serge Saxonov, has a CEO approval rating of 68/100, as scored by 50 10X Genomics employees, placing Serge Saxonov in the Top 50% of similarly-sized companies for CEO score. The company has only been in existence for seven years. Under his leadership, 10x Genomics has successfully launched several groundbreaking genomics and single-cell analysis technologies. ; Began shipping Xenium Prime 5K, which measures 5,000 genes and features an enhanced chemistry to deliver excellent per-gene sensitivity, improved specificity and spatial Serge Saxonov, Iraj Daizadeh, Alexei Fedorov and Walter Gilbert* Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA Received August 23, 1999; Revised and Accepted October 25, 1999 ABSTRACT To aid studies of molecular evolution and to assist in gene prediction research, we have constructed an Results. t-SNE projection of approximately 10,000 mouse brain cells derived from the combined cortex, hippocampus and ventricular zones of embryonic day 18 brain tissue. Analysis of nucleic acid sequences. Serge Saxonov has a Bachelor in Applied Mathematics from Harvard University in 1999 and a PhD in Biomedical Informatics from Stanford University in 2006. Chief Executive Officer Serge Saxonov discusses the company's strategy and performance amid the Covid-19 pandemic with Bloomberg's Vonnie Quinn on "Bloomberg Markets. (NASDAQ: TXG) has recently seen a transaction from its top executive. GEM architecture It takes a village to curate amazing lists from this rather busy group of leaders from all over the world. Shauna Clark. 55. But Serge Saxonov, cofounder 10x Genomics, Inc. Mr. Create your alert to follow the career of Serge Saxonov. 1073/pnas. Born into the family of minor Russian nobility, he was the son of Dmitry Feodorovich Sazonov (1825-1860) and his wife, Baroness Yermioniya Alexandrovna Frederiks (Freedericksz). Wholly Trinity: 10x Genomics Focuses on Three Existing Platforms: Speaking exclusively with GEN Edge, CEO Serge Saxonov discusses Xenium, Visium improvements planned for this year, and defends patent lawsuits. 7. 10x Genomics, Inc. law comprehensive legal Serge Saxonov and Benjamin Hindson worked at a company called QuantiLife, which was bought out by Bio-Rad in 2011. Serge wears baggy indigo-colored shorts with a pattern of a lighter blue running just 10x Genomics CEO Serge Saxonov joins Yahoo Finance to discuss biotechnology innovation, progress in genomics, and macroeconomic headwinds. 34% of the company’s shares, worth $58. Get personalized recommendations, and learn where to watch across hundreds of streaming providers. , Serge Saxonov presently is Chief Executive Officer & Director at this company. [1] The worsted variety is used in making military uniforms, suits, greatcoats, and trench coats. (NASDAQ:TXG) Q4 2020 Results Conference Call February 17, 2021 4:30 PM ETCompany Participants. dc. Of this total $544,688 was received as a salary, $380,363 was received as a bonus, $2,399,071 was received in stock options, $4,961,928 was awarded as stock and $0 came from other types of compensation. Other executives include Ben Hindson, Chief Scientific Officer, Co-founder, President; Michael Schnall-Levin, Chief In 2012, Serge co-founded 10x Genomics with Ben Hindson and Kevin Ness. 69), decreasing direct ownership by 0. He received a doctorate from Stanford University and Serge Saxonov is currently Chief Executive Officer and Director at 10X Genomics - View - 10X Genomics org chart. 7k salary. Serge has made over 59 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. After growing its Xenium In Situ single-cell spatial imaging platform into its third successful technology family last year, 10x Genomics has no Founder of 10X Genomics, Inc. (NASDAQ:TXG) Q4 2021 Earnings Conference Call February 16, 2022 4:30 PM ETCompany Participants. The average tenure of the management team and the board of directors is 2. 186530. Image result for precision medicine magazine covers The estimated Net Worth of Serge Saxonov is at least $48. CEO of 10x Genomics Inc (30-Year Financial, Insider Trades) Serge Saxonov (insider trades) sold 15,000 shares of TXG on 12/07/2021 at an average price of $145. -based gene sequencing company. (NASDAQ:TXG) Q1 2020 Results Conference Call May 11, 2020 4:30 PM ETCompany ParticipantsCarrie Mendivil - Investor RelationsSerge Saxonov Serge Saxonov Co-founder and CEO at 10x Genomics 1y Report this post We built 10x to excel at creating new technologies for the life sciences to accelerate the mastery of biology and ultimately A serge suit. Health, research, business, cataclysms – Clairvoyant/Psy The Sunday Times’ tech correspondent Danny Fortson brings on Serge Saxonov, founder of 10x Genomics, to talk about the end of normalcy (3:00), his high-end espresso machine for biology (4:20), delivering on the promise of genomics (6:20), how 10x is contributing to the coronavirus vaccine race (8:00), why a vaccine is theoretically achievable Serge Saxonov Co-founder and CEO at 10x Genomics 2y Report this post We built 10x to excel at creating new technologies for the life sciences to accelerate the mastery of biology and ultimately I had the pleasure of interviewing Serge Saxonov. , Aug. Video Transcript In an interview with AlphaStreet, chief executive officer Serge Saxonov said, “ At 10x, we try to see where the world is going and work backwards from that to determine what is best for our customers. (NASDAQ:TXG) Q4 2019 Earnings Conference Call February 18, 2020 4:30 PM ETCompany Participants. Publication: GEN Edge. 612 đô la. Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co Serge Saxonov [00:55:33] Yeah, you know, it's amazing. Your input is valuable to us so please don't hesitate to contact us at 10X Genomics uses technology such as AI to explore and advance spatial biology. Author: Alex Philippidis Authors Info & Affiliations. Like Crono, Serge is a silent main protagonist. contributor. [3] Prior to starting the company, Serge Saxonov is CEO/Co-Founder at 10X Genomics Inc. [2] Ness left 10x Genomics in December 2016 [4] and in 2018, Justin McAnear, Tesla's former finance chief Serge Saxonov. Most recently he exercised 14,935 units of TXG stock worth $17,922 on 27 December 2023. CEO of 10x Genomics Serge Saxonov discusses his thoughts on the company's growth and competition with "Squawk Alley". Most recently he sold 6,749 units of TXG stock worth $152,055 on 22 August 2024. Total pay for CEO Serge Saxonov includes US$544. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company si 10x Genomics co-founder and CEO, Serge Saxonov, PhD, discusses his career in genomics and science on GEN’s Close to the Edge. Serge Saxonov Net Worth (2024) | wallmine GB Serge Saxonov is on Facebook. Dr. , Aug. At any given distance from the transcription start site (TSS), exons are similarly enriched for CpGs compared to introns. 10X Genomics Inc (10X Genomics) is engaged in developing an innovative genomics platform. 10X Genomics TXG under CEO Serge Saxonov. Facebook gives people the power to Serge has made over 54 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June Wholly Trinity: 10x Genomics Focuses on Three Existing Platforms: Speaking exclusively with GEN Edge, CEO Serge Saxonov discusses Xenium, Visium improvements planned for this year, and defends patent lawsuits. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception. 0G . Saxonov said the focus is on tapping the unfolding opportunities. Serge Saxonov, CEO and co-founder of 10x Genomics, kicked off Monday’s sessions with an overview of the company’s overall progress in its Visium, Chromium, and Xenium platforms. This information is according to proxy statements filed for Serge Saxonov, co-founder and chief executive officer of Bay Area-based 10X Genomics, started the biotech company in 2012. 10x Genomics to hold its Annual General Meeting on 11th of June. Last week our CEO, Serge Saxonov, appeared on Sirius XM's Launch Pad powered by Wharton Business School. (NASDAQ:TXG) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ETCompany Participants. 04 a share. Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov - Chief The estimated net worth of Serge Saxonov is at least $16 Million dollars as of 2024-12-15. Founded in 2012 by Saxonov, Ben Hindson and Kevin Ness, 10x went public in September 2019 and has grown to more than 1,100 employees. $688,000 was received as Total Cash, $10,964,463 was received as Equity and $48,522 was received as Pension and other forms of compensation. If you have additional information or corrections regarding this mathematician, please use the update form. (NASDAQ: TXG), recently reported the sale of 6,693 shares of Class A common stock. Behind every breakthrough is an extensive network of talented individuals contributing their unique perspectives, backgrounds, and areas of expertise. 6 million in the first half of this year on Serge Saxonov Summary. Although CpGs occur ≈25% as often over the whole human genome as would be expected based on the GC content, their presence is elevated relative to this background level in exons and upstream regions of genes (Table 1). 42 years. Most recently he sold 4,877 units of TXG stock worth $118,511 on 22 May 2024. date. Serge has made over 60 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. Ness and Eduard Serge Saxonov. Prior to 10x Genomics, Serge was Vice President of I'm thrilled to announced that I have recently joined 10x Genomics as an Account Executive in New England! Excited to advance and support the nexus Merry Christmas! The Garvan Serge Saxonov Co-Founder and Chief Executive Officer 10x Genomics. accessioned: 2015-07-07T20:02:51Z Serge Saxonov, co-founder and chief executive officer of 10x Genomics, Our public offering allows us to continue the journey we’ve started to master biology and advance human health,” Saxonov told BioSpace. Chief Executive Officer Saxonov Serge gifted 1,850 shares and sold $91,612 worth of shares (6,693 units at $13. “We’ve been making significant advances across many different areas spanning hardware, chemistry, and software—pushing the state of the art—and we will put these advances into the new platform Serge Saxonov founded 10X Genomics, Inc. Roberts: 10x Genomics, Inc. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. There are 6 executives at 10x Genomics getting paid more, with Serge Saxonov having Shares of Bay Area-based 10X Genomics surged more than 35% on its first day of trading to close at $52. Serge Saxonov used to own units in Class B Common Stock but no longer holds any shares there. be/YqeMpto1dQEThis installment of the NextTech Speaker series features Serge Saxonov, co-founder of 10x Genomics, sharing the View Serge Saxonov's email address (s*****@10xgen***. Cassie Corneau - Investor Relations and Strategic Finance Serge Saxonov - Chief View FREE Public Profile & Reputation for Serge Saxonov in Oakland, CA - Court Records | Photos | Address, Emails & Phone | Reviews | $100 - $149,999 Net Worth Serge Saxonov’s Post Serge Saxonov Co-founder and CEO at 10x Genomics 2y Edited Report this post Recently I read about some founders who wish they had set up better boards early in their history The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. com) and phone number. Serge Saxonov is the CEO of 10x Genomics Inc and owns about 1,109,291 shares of 10x Genomics Inc (TXG) stock worth over $16 Million. genprowebdirectory Facebook Linkedin RSS Twitter Youtube Serge Saxonov, CEO and co-founder of 10X Genomics, summarized the landscape of single-cell sequencing and announced a new in situ product. He then attended Holsord State University. (NASDAQ:TXG) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ETCompany Participants. Its counterpart, silk serge, is used for linings. 10x Genomics is a major player in gene sequencing technology Table of Contents : 1. (NASDAQ: TXG), gần đây đã báo cáo về việc bán 6. Ben Hindson Co-Founder and Chief Scientific Officer 10x Genomics. NEW YORK – Single-cell analysis firm 10x Genomics didn't need to raise more than $357. Publication date 1914 Topics IIIT Collection digitallibraryindia; JaiGyan Language English Item Size 1. (แนสแด็ก:TXG) เพิ่ง Table of Contents : 1. Instead of delving too deeply in specific product announcements, Saxonov emphasized the strength of the 10x team, the mergers and acquisitions that have led to the 10x Genomics' CEO is Serge Saxonov, appointed in Jul 2012, has a tenure of 12. 6878 đô la mỗi cổ phiếu, dẫn đến tổng giá trị giao dịch khoảng 91. Author: Alex Philippidis Authors Share your videos with friends, family, and the world Saxonov also announced coming upgrades to 10x's Chromium and Xenium platforms during his presentation. “Both companies have made significant technical advances, which will serve as a powerful foundation for future product development at 10x,” said cofounder and CEO Serge Saxonov. January 24, 2022 by juliourvina_icic. Salary: $503,750: Bonus: $291,340: Value of Stock Awards: $9,138,921: Value of Option Awards: $8,828,695: Non-Equity Incentive Plan Compensation: $0: Change in 10x Genomics is paving the way for a new understanding of biology, human health, and disease. A number of these reports have been inaccurate. Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. Serge Saxonov, Ben Hindson and Kevin Ness got together and founded 10x Genomics in 2012. Name Total COMPENSATION; Bryan E. With a robust skill set that includes Bioinformatics, Genomics, Start-ups, Personalized Medicine, Molecular Biology and more. 2. Serge Saxonov Net Worth (2024) | wallmine NZ Serge Saxonov: CEO Pay $8,286,049: Median Employee Pay $223,138: CEO Pay Ratio 37:1: Board of Directors in 10X GENOMICS INC. In addition, he makes $2,362,960 as Chief Executive Officer, Co-Founder, and Director at 10x Genomics. See more Serge Saxonov co-founded 10x Genomics in 2012. (NASDAQ:TXG) Q2 2020 Results Conference Call August 11, 2020 4:30 PM ETCompany Participants . His challenge has been to get vastly different disciplines — 10X Genomics's Chief Executive Officer, Co-Founder is Serge Saxonov. 5 million in yesterday's initial public offering. 29M, comprised of 6. 97% to 872,574 units (SEC Form 4) 11/25/24 4:53:14 PM ET Serge Saxonov ประธานเจ้าหน้าที่บริหารของ 10x Genomics, Inc. Saxonov, who started his corporate career as the founding R&D Architect at the personal genetics company 23andMe, ultimately hopes that filling the gaps left by short-read sequencing will help advance medical discoveries that rely on understanding the most difficult-to-sequence regions of the genome. Serge Wolkner is a Sordish driver who serves as the personal driver of President Anton Rayne. This work was supported by a predoctoral fellowship from the National Science Foundation, the NIH Cell and Molecular Biology Training Grant and a grant from the National Human Genome Research Institute (HG02235). Serge Saxonov Net Worth (2023) | wallmine /s/ Eric S. In his past career he was Director-Research & Development at 23andMe, Inc. He added that the company is at a nascent stage and exuded confidence in Letter from Serge Saxonov. Serge shared a deep dive into 10x Genomics and spoke about the growth of the company since A good example of a biotech CEO getting regulatory compliance right is Serge Saxonov. We would like to thank Nikhil Deogun, Mitra S. Markets; Tools Portfolios Serge Saxonov Net Worth Serge Saxonov, CEO, Co-founder, and Ben Hindson, Chief Scientific Officer, President, Co-founder of 10x Genomics, which makes and sells technology to research labs and pharma companies that Serge Saxonov Co-founder and CEO at 10x Genomics 2y Report this post It was awesome to host yesterday's Grand Opening event celebrating our new Singapore manufacturing facility and APAC commercial Serge C Saxonov, age 47, lives in Piedmont, CA. 6% salary and 93. The company was founded in 2012 by Serge Saxonov and Ben Hindson, who had previously worked together at the biotech company Bio-Rad Laboratories. Serge Saxonov has 2 emails Recently, 10x Genomics CEO Serge Saxonov was asked about the novel coronavirus, 2019-nCoV, and what it will take to address this and other viral threats to worldwide human health. Serge sports an athletic build, messy dark blue hair under a red bandana with gold patterning. What has 23andMe invented, and how will it change the future of genetics and health? Serge and Alex take you behind the scenes of the architecture, product design, and science of 23andMe. Serge Saxonov and Alexander Wong 23andMe, Inc. 693 cổ phiếu phổ thông loại A. Serge Saxonov - CEO and Co-Founder Justin McAnear - CFO Brad Crutchfield - Chief Serge Saxonov owns 882,467 units of Class A Common Stock which is worth $19,987,877. A major bottleneck for AI in the field, though, is a lack of data needed to train these models, such as the gene and protein sequences from a broad variety of species. Health, research, business, cataclysms – Clairvoyant/Psy Serge Saxonov, Giám đốc điều hành của 10x Genomics, Inc. By marrying Anna Borisovna von Neidhardt (1868-1939), he became brother-in-law of Prime 10X Genomics's Chief Executive Officer, Co-Founder is Serge Saxonov. 4 Century of Biology. Serge Saxonov - Co-Founder & Chief Executive Officer Justin McAnear - Chief Serge has made over 61 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. While Serge Saxonov is on Facebook. Recent Highlights. Eric Jaschke - Director of IR and Strategic Finance Serge Saxonov - CEO and Co 10x Genomics, Inc. Saxonov owns over 4,660 units of 10x Genomics stock worth over $30,555,125 and over the last 4 years he sold TXG stock worth over $15,636,009. 6 Million dollars as of 4 March 2024. Serge Saxonov’s Post Serge Saxonov Co-founder and CEO at 10x Genomics 1y Serge Saxonov, the Chief Executive Officer of 10x Genomics, Inc. It was a good day of trading for the Pleasanton, Calif. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. This information is derived from proxy statements filed for the 2021 fiscal year. On its website, the company describes its mission as “[delivering 10x Genomics, Inc. Key Insights. Most recently he exercised 3,000 units of TXG stock worth $3,600 on 12 December 2022. Revenue was $153. CEO of 10x Genomics Inc (30-Year Financial, Insider Trades) Serge Saxonov (insider trades) sold 15,000 shares of TXG on 03/12/2021 at an average price of $157. See Serge Saxonov's compensation, career history, education, & memberships. Serge Silberman (1 May 1917 – 22 July 2003) was a French film producer known for his collaborations with several major European and Japanese filmmakers, including Luis Buñuel, Akira Kurosawa, Jean-Pierre Melville, René Clément, Jacques Becker, and Nagisa Oshima. At 10X Genomics, the most compensated executive makes $720,000, annually, and the lowest compensated makes $76,509. total yearly compensation is $8. Patent number: Joining the call today are Serge Saxonov, our CEO and Co-Founder, and for his first earnings call with 10x, Adam Taich, our new Chief Financial Officer. author: Serge Sazonov dc. 10X Genomics Co-founder & CEO Nov 2012 10x Genomics co-founder and CEO Serge Saxonov, PhD. Serge Saxonov holds a 2000 - 2006 PhD in Biomedical Informatics @ Stanford University. 10X began filing patent applications on an architecture called “gel bead in emulsion” (GEM). The word is also used for a high-quality woven woolen fabric. To submit students of this mathematician, please use the new data form, noting this mathematician's MGP ID of 287693 for the advisor ID. Most recently he sold 4,660 units of TXG stock worth $205,040 on 4 March 2024. . "This is not, strictly speaking, a financing round in the sense that we needed cash to keep going," 10x CEO and Cofounder Serge Saxonov told GenomeWeb in the Nasdaq offices, following the close of the market. Other executives include Ben Hindson, Chief Scientific Officer, Co-founder, President; Michael Schnall-Levin, Chief Technology Officer, Founding Scientist and 8 others. From λ, together with the volume of each replicate PCR and the total number of replicates analyzed, an estimate of the absolute target DNA concentration is calculated. The median estimated compensation for executives at 10X Genomics including base salary and bonus is $273,737, or $131 per hour. Cổ phiếu đã được bán vào ngày 22 tháng 11 với giá trung bình là 13. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. 6 Serge has made over 38 trades of the 10x Genomics stock since 2019, according to the Form 4 filled with the SEC. French serge is a softer, finer variety. Eric Jaschke - Director of Investor Relations and Strategic Finance Serge Saxonov Serge Saxonov's 12 research works with 2,774 citations and 6,049 reads, including: Supplementary Material 3 © 10X GENOMICS, INC. The 10x Genomics, Inc. Prior to 10x Genomics, Serge was VP of Applications at QuantaLife, where he was responsible for building content, driving new He co-founded 10x in 2012 in California’s Bay Area, with the aim of being at the intersection of biology and technology. Search our database of over 100 million company and executive profiles. Join Facebook to connect with Serge Saxonov and others you may know. Share prices, which are sold on the Nasdaq under the ticker symbol “TXG” had climbed as much as 49% during 10x CEO Serge Saxonov spoke at the Financial Times Live (FT Live) Global Pharmaceutical and Biotechnology Conference about 10x, single cell, immunology, and the future of life sciences. Read court documents, court records online and search Trellis. The company’s product pipeline comprises chromium X series, chromium connect, and chromium controller. The headquarters is located in Pleasanton, California with Serge Saxonov serving as the Chief Executive Officer and Ben Hindson as President. Toggle navigation corporation wiki 10x Genomics is a biotech company based in California that provides innovative solutions for genomic research. 10X Genomics Inc. Born in the small town of Nehir, between Erzaren and Deyr, Wolkner attended the Deyr Dastnurity School. PMID: 16432200 PMCID: PMC1345710 DOI: 10. He is Chief Executive Officer & Director at this company. Facebook gives people the power to share and makes the world more open and connected. Find ratings and reviews for the newest movie and TV shows. (NASDAQ:TXG) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ETCompany Participants. The Sunday Times’ tech correspondent Danny Fortson brings on Serge Saxonov, founder of 10x Genomics, to talk about the end of normalcy (3:00), his high-end espresso machine for biology (4:20), delivering on the promise of genomics (6:20), how 10x is contributing to the coronavirus vaccine race (8:00), why a vaccine is theoretically Serge Saxonov made $11,700,985 in total compensation as Chief Executive Officer and Director at 10x Genomics Inc in 2021. ” Tim Clackson Theseus Pharmaceuticals (See Disclosures) "The Foresite team contributed meaningful scientific and strategic insights that supported our View Part 1 Here: https://youtu. This page is a promotion for Advisor 1: Douglas Lee Brutlag Advisor 2: Serafim Batzoglou No students known. [3] Prior to starting the company, Saxonov was the founding architect, and director of research and development at 23andMe. Saxonov is also on the board of 10x Technology LLC. Total compensation is similar to the industry average IMDb is the world's most popular and authoritative source for movie, TV and celebrity content. Whitaker, as Attorney-in-Fact for Serge Saxonov: 11/18/2024 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Find their contact information including current home address, phone number 650-852-9468, background check reports, and property record on Whitepages People Search, the most trusted online directory. As these dynamics persist, especially under a difficult macro backdrop, our revenue growth this year will be lower than our previous expectations," said Serge Saxonov, Co-founder and CEO of 10x Serge (セルジュ, "Seruju"?) is the main protagonist of Chrono Cross. He has defined the company’s vision and strategy Serge Saxonov 1 , Paul Berg, Douglas L Brutlag. and Vice President-Applications at QuantaLife, Inc. Saxonov, co-founder and CEO of 10x Genomics, has led the company since its inception in 2012. directly owns 3. Coat of arms of the Sazonov family, tracing back their noble lineage back to the 17th century. 0510310103 Abstract A striking feature of the human genome is the dearth of CpG dinucleotides (CpGs) interrupted occasionally by CpG islands (CGIs Serge Sazonov. Serge Saxonov is the Co-Founder and Chief Executive Officer at 10x Genomics. The company's core technology is based on microfluidics and molecular barcoding, which allow View Part 2 Here: https://youtu. It lost $22. Serge Saxonov is on Facebook. PLEASANTON, Calif. He is also on the board of 10x Technology LLC. where λ is the average number of target DNA molecules per replicate reaction and p is the fraction of positive end-point reactions. muntv rbplb fzimxgp esvzo kynasvrs stfup tepo qmsmz lmhlym dlntrs